GBP/USD Upside Intact, EUR/GBP Outlook Bearish

GBP/USD, EUR/GBP Price Analysis & News

GBP Stands to Outperforming on Vaccine Rollout
EUR/GBP Outlook Remains Weak

GBP Stands to Outperform on Vaccine Rollout

A rather quiet start to the week as market participants await key risk events in the form of the FOMC meeting and several large-cap earnings. Nonetheless, risk sentiment is off to a firm start, which has come to the benefit of the Pound this morning, which hovers around the 1.37 handle. As I had mentioned last week, the vaccine trade is in full swing for Sterling, which stands to outperform against its counterpart given the successful vaccine rollout program thus far. This is particularly the case vs the Euro, which has faced supply disruptions with AstraZeneca cutting deliveries by 60% in Q1.

Recommended by Justin McQueen

Download our fresh Q1 2021Pound Forecast

EUR/GBP Outlook Remains Weak

Taking a look at the technicals, the outlook for EUR/GBP remains weak with last weeks brief break below key support at 0.8860 suggesting as much. Alongside this, the subsequent bounce back above 0.8900 had been quickly faded, signalling that the market is fading rallies in the cross. As such, with 0.8860 back in focus, another break below places the Jan 21st low in focus at 0.8839. On the topside, resistance resides at 0.8900 and 0.8915-20.

EUR/GBP Chart: Daily Time Frame

Source: Refinitiv

of clients are net long.

of clients are net short.

Change in	Longs	Shorts	OI
Daily	17%	10%	14%
Weekly	-30%	63%	-6%

GBP Paring Friday’s Overreaction

The uptrend remains for GBP/USD with market participants quick to buy the dip. Friday’s price action following the unsurprisingly weak PMI figures can be described as somewhat of an overreaction and thus today’s tone appears to be a paring of Friday’s selling. Alongside this, while the short-term risks over COVID remain a concern, the Pound continues to benefit from the vaccine rollout plan, suggesting that economies that have been worst affected, stands to benefit the most.